CClinicalTrials.gg
Not yet recruitingNCT07537114Updated Aug 28, 2026

Effects of Music During Walking on Pain and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis

An interventional study of Rhythmic Auditory Stimulation with music and Rhythmic Auditory Stimulation with metronome in Knee Osteoarthritis, sponsored by Boston University Charles River Campus. Not yet recruiting. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
50 Years to 85 Years
Sex
All
01

Study summary

The purpose of this research study is to compare muscle activation, changes in pain sensitivity, and brain function, between different walking conditions, including walking to music, walking to metronome, and walking without music or metronome.

Read the detailed description

Participants with knee osteoarthritis (OA) will complete a single study visit which will include three walking tasks, each being 25 minutes in duration. The walking tasks will include walking without music or metronome, walking to metronome, and walking with music. Participants muscle activity, brain activity, and movements will be recorded during these tasks. Participant's pressure pain threshold will be recorded at the beginning and after each task.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • music
  • rhythmic auditory stimulation
  • knee pain
03

Who can participate

Ages eligible
50 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Have activity related pain
  • Experience morning knee stiffness ≤ 30 minutes
  • Knee pain on most days for 3 months or more
  • Able to walk at least 20 minutes with assistance
  • Average overall knee pain severity of ≥= 4 on a 11-point numeric rating scale during previous week
  • BMI ≤ 40
  • Able to communicate using English at a level to understand the study procedures and informed consent

Exclusion criteria

Exclusion Criteria:

  • Contraindications to exercise
  • Joint replacement in either hip, knee, or ankle
  • History of other disease that may involve the index joint including inflammatory joint disease such as rheumatoid arthritis, seronegative spondyloarthropathy (eg, ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease related arthropathy), crystalline disease (eg, gout or pseudogout), lupus erythematosus, knee joint infections, Paget's disease affecting the knee, or knee joint tumors.
  • Previous knee osteotomy in either knee
  • Other health conditions that impact motor functioning or prevent participation (e.g., stroke, Parkinson's disease, Alzheimer's disease, Multiple Sclerosis, diabetic neuropathy, etc.)
  • Corticosteroid or hyaluronic acid injections in either knee in the previous 3 months
  • Pregnancy (self-report)
  • Suspected or known drugs or alcohol abuse
  • Mini-mental State Examination (MMSE) score \< 24
  • Hearing impairments
  • Pain in lower back or legs that is greater than knee pain
04

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Rhythmic auditory stimulation during walking

    All participants will be exposed to different walking conditions including music, metronome, and no music or metronome

    Behavioral: Rhythmic Auditory Stimulation with music · Behavioral: Rhythmic Auditory Stimulation with metronome · Behavioral: Control

Interventions

  • BehavioralRhythmic Auditory Stimulation with music

    Walking to rhythmic Auditory Stimulation with music

  • BehavioralRhythmic Auditory Stimulation with metronome

    walking to rhythmic Auditory Stimulation with metronome

  • BehavioralControl

    Walking to no music or metronome

05

What researchers measure

Primary outcomes

  1. Exercise-Induced Hypoalgesia (EIH)

    Change in pressure pain threshold (PPT) from baseline to after each walking task

    Time frame: Baseline

  2. medial quadriceps - medial hamstrings muscle coactivation

    Medial quadriceps-medial hamstrings muscle co-activation in each walking task will be assessed using surface electromyography

    Time frame: Baseline

Secondary outcomes

  1. Medial quadriceps- medial gastrocnemius muscle coactivation

    Medial quadriceps-medial gastrocnemius muscle co-activation in each walking task will be assessed using surface electromyography

    Time frame: Baseline

  2. lateral quadriceps- lateral hamstrings muscle coactivation

    Lateral quadriceps-lateral hamstrings muscle co-activation in each walking task will be assessed using surface electromyography

    Time frame: Baseline

  3. lateral quadriceps - lateral gastrocnemius muscle coactivation

    Lateral quadriceps-lateral gastrocnemoius muscle co-activation in each walking task will be assessed using surface electromyography

    Time frame: Baseline

Other outcomes

  1. Prefrontal cortex activation

    Prefrontal cortex (PFC) brain activation during each walking task will be assessed using functional near-infrared spectroscopy (fNIRS)

    Time frame: Baseline

  2. Supplementary Motor Area activation

    Supplementary Motor Area (SMA) brain activation during each walking task will be assessed using functional near-infrared spectroscopy (fNIRS)

    Time frame: Baseline

  3. Auditory-motor synchronization

    difference between actual cadence and target cadence in each walking ask (except walking to no music or metronome)

    Time frame: Baseline

  4. physical activity enjoyment

    Modified Physical Activity Enjoyment Scale (PACES) score after each walking task. Range is 7-49 with higher scores indicating greater enjoyment.

    Time frame: Baseline

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: Yes — Requests will be considered on an individual basis

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07537114
Lead sponsor
Boston University Charles River Campus
Responsible party
Sponsor
First posted
Apr 17, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Aug 28, 2026

Study contacts

Deepak Kumar, PT, PhD
Contact
kumard@bu.edu
617-358-3037
Yiwen Yang, DPT
Contact
ywyang@bu.edu
Deepak Kumar, PT, PhD
principal investigator · Boston University Charles River Campus

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion